Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients
Clinical trial NCT04809181 · UNKNOWN
Trial details
- NCT number
- NCT04809181
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-19
- Primary completion
- 2024-03-19
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.